News Letter to Shareholders and Corporate Update Continue Reading Previous Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offeringNext Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Related Stories News Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation News Syntheia Signs Definitive Agreement for Call Center Acquisition News Intellistake Technologies Corp. Announces Completion of Change of Business, Name Change and Ticker Symbol Change Digital Transformation News CORRECTING and REPLACING Vouched Developing Integration in Epic Toolbox Under Construction for Remote Identity Verification News Wells Fargo Scandal Drove Borrowers to Fintech Lenders, UC Davis Study Suggests News CertiK Cements Institutional Presence After CEO’s Strategic Engagements in Hong Kong
